← Back to all trials
Enrolling By Invitation
NCT07637162
Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia
Conditions: Fibromyalgia
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE3
Enrollment: 300
Sponsor: Axsome Therapeutics, Inc.
Location: Clinical Research Site Little Rock Arkansas
Summary
This is a Phase 3, multi-center, 52-week, open-label trial to evaluate the long-term safety and efficacy of AXS-14 in the management of fibromyalgia.
Eligibility Criteria
Inclusion Criteria:
* Participation in AXS-14-FM-301.
Exclusion Criteria:
* Unable to comply with study procedures.
* Medically inappropriate for study participation in the opinion of the Investigator.
Source: ClinicalTrials.gov (NCT07637162). StuddyBuddy aggregates publicly available trial information.